Impact of Protamine infusion Rate on Activated Clotting Time in Cardiac Surgery Patients undergoing Cardiopulmonary Bypass

Impact of Protamine Infusion Rate on Activated Clotting Time

Authors

  • Natchada Supakitjarern -

Keywords:

protamine, cardiopulmonary bypass, open heart surgery

Abstract

Cardiac surgery is a complex surgery that use cardiopulmonary bypass machine for work as lung and  heart for maintain oxygenation and circulation. Use of  cardiopulmonary bypass machine increase risk clot and  embolization due to abnormal surface contact between  patient' blood volume and circuit system. Heparin must be  given to maintain unclotted and heparinized system. After  finished surgery the coagulation system that prolong by  given heparin must be reverse by protamine for normal  coagulation. This double blinded randomized controlled  study compared two protamine dosing systems between  protamine rate infusion 5 mg/min and total amount drip in  15 min. This study found that activated clotting time after reverse by two protamine systems were equivalence. Thus,  a 15-minute infusion of protamine to counteract  the action  of heparin is equivalent to that of 5 mg/min

Author Biography

Natchada Supakitjarern, -

Department of Anesthesiology, Buddhachinaraj Phitsanulok Hospital, Phitsanulok 65000

References

Freundlich RE, Duggal NM, Housey M, Tremper TT, Engoren MC, Kheterpal S. Intraoperative medications associated with hemodynamically significant anaphylaxis. J Clin Anesth 2016;35:415-23.

Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011;91(3):944-82.

Boer C, Meesters MI, Veerhoek D, Vonk ABA. Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review. Br J Anaesth 2018;120(5):914-27.

Kimmel SE, Sekeres M, Berlin JA, Ellison N. Mortality and adverse events after protamine administration in patients undergoing cardiopulmonary bypass. Anesth Analg 2002;94(6):1402-8.

Weiler JM, Gellhaus MA, Carter JG, Meng RL, Benson PM, Hottel RA, et al. A prospective study of the risk of an immediate adverse reaction to protamine sulfate during cardio pulmonary bypass surgery. J Allergy Clin Immunol 1990;85(4):713-9.

Welsby IJ, Newman MF, Phillips-Bute B, Messier RH, Kakkis ED, Stafford-Smith M. Hemodynamic changes after protamine administration: association with mortality after coronary artery bypass surgery. Anesthesiology 2005;102(2):308-14.

Khan NU, Wayne CK, Barker J, Strang T. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph. Eur J Anaesthesiol 2010;27(7):624-27.

Apnis A, Sehgal S, LeffJ. Intraoperative management of carotid endarterectomy. Anesthesiol Clin 2014;32(3):677-98.

Bohmer A, Defosse J, Geldner G, Rossaint R, Zacharowski K, Zwissler B, et al. The updated ASA classification. Anasth Intensiv Med 2021;62:223-27.

Tongyoo S. Monitoring central venous pressure (Part 1/2). Clin Crit Care [Internet]. 2016 Dec 28 [cited 2022 Aug 18];24(3):7-12. Available from: https://he02.tci-thaijo.org/index.php/ccc/article/view/253090

Downloads

Published

2022-08-26